Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the long-term safety and efficacy of CNTO 136 (sirukumab) in participants with rheumatoid arthritis (RA) who are unresponsive to treatment with modifying antir...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Janssen Research & Development, LLC
Collaborators
NCT05961592 · Arthritis, Rheumatoid
NCT07017686 · Arthritis, Rheumatoid
NCT05038553 · Arthritis, Rheumatoid, Pain
NCT05790356 · Arthritis, Arthritis, Rheumatoid, and more
NCT05657847 · Arthritis, Rheumatoid, Arthritis, Psoriatic, and more
Birmingham, Alabama
Glendale, Arizona
Mesa, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions